These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33178699)

  • 1. The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective.
    Lademann F; Hofbauer LC; Rauner M
    Front Cell Dev Biol; 2020; 8():586031. PubMed ID: 33178699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
    Bordukalo-Nikšić T; Kufner V; Vukičević S
    Front Immunol; 2022; 13():869422. PubMed ID: 35558080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effects of Combined Bone Morphogenetic Protein 2, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor on Osteoclast Differentiation and Activity.
    Wu H; Yin G; Pu X; Wang J; Liao X; Huang Z
    Tissue Eng Part A; 2021 Nov; 27(21-22):1387-1398. PubMed ID: 33632010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts.
    Kaneko H; Arakawa T; Mano H; Kaneda T; Ogasawara A; Nakagawa M; Toyama Y; Yabe Y; Kumegawa M; Hakeda Y
    Bone; 2000 Oct; 27(4):479-86. PubMed ID: 11033442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
    Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
    J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
    Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
    Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.
    Pederson L; Ruan M; Westendorf JJ; Khosla S; Oursler MJ
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20764-9. PubMed ID: 19075223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
    Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
    J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Smad Dependent TGF-β and BMP Signaling Pathway in Bone Remodeling and Therapies.
    Zou ML; Chen ZH; Teng YY; Liu SY; Jia Y; Zhang KW; Sun ZL; Wu JJ; Yuan ZD; Feng Y; Li X; Xu RS; Yuan FL
    Front Mol Biosci; 2021; 8():593310. PubMed ID: 34026818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways.
    Miao X; Yuan J; Wu J; Zheng J; Zheng W; Wang F; Wang C; Li X; Liu S; Shi Z; Li J
    Spine (Phila Pa 1976); 2021 Feb; 46(4):E234-E242. PubMed ID: 33156278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.
    Blackwell KA; Hortschansky P; Sanovic S; Choudhary S; Raisz LG; Pilbeam CC
    Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):76-80. PubMed ID: 19744575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro.
    Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S
    Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
    Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
    Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
    Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2.
    Ichikawa K; Ohta Y; Mamoto K; Mizokawa S; Minoda Y; Imai Y; Takaoka K; Nakamura H
    Biochem Biophys Res Commun; 2016 Nov; 480(3):314-320. PubMed ID: 27746180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
    Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dentin resorption and cementum-like tissue formation by bone morphogenetic protein application.
    Miyaji H; Sugaya T; Kato K; Kawamura N; Tsuji H; Kawanami M
    J Periodontal Res; 2006 Aug; 41(4):311-5. PubMed ID: 16827725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.